Drug Design, Development and Therapy (Aug 2022)

Efficacy and Safety of Remimazolam Besylate versus Dexmedetomidine for Sedation in Non-Intubated Older Patients with Agitated Delirium After Orthopedic Surgery: A Randomized Controlled Trial [Corrigendum]

  • Deng Y,
  • Qin Z,
  • Wu Q,
  • Liu L,
  • Yang X,
  • Ju X,
  • Zhang Y,
  • Liu L

Journal volume & issue
Vol. Volume 16
pp. 2681 – 2682

Abstract

Read online

Deng Y, Qin Z, Wu Q, et al. Drug Des Devel Ther. 2022;16:2439‒2451. The authors have informed the journal that Remimazolam Tosilate was used in this study, not Remimazolam Besylate as indicated throughout the paper. The authors apologize for any confusion this may have caused.